SynBioBeta Speaker
Elliot Hershberg
Amplify Partners
Partner, Author
Elliot Hershberg is a Partner at Amplify Partners and the author of The Century of Biology newsletter. At Amplify, he invests in early-stage digital biology businesses building platforms and infrastructure to accelerate biomedical progress. His newsletter covers data, companies, and ideas from the frontier of biology. Elliot earned his PhD in Genetics from Stanford University. Previously, he worked as a software engineer building tools for genomics researchers.
Sessions Featuring
Elliot
This Year
•
-
General
Bold VC Perspectives: How Biotech Gets Funded Today
A curated lineup of leading biotech VCs, each delivering a 5-minute rapid-fire briefing covering: fund focus, investment thesis, selection process, and their most actionable advice for fundraising in the current market
Featuring
Ivan Jaubert
SynBioBeta
Director of Entrepreneurship
Startup-ecosystem builder connecting founders, investors, and corporates.
Omri Amirav-Drory
NFX
General Partner
Scientist-founder VC: built Genome Compiler, now backs techbio.
Blair Willette
KdT Ventures
Investor
Nicole Sonnert
Playground Global
Investment Associate
Elliot Hershberg
Amplify Partners
Partner, Author
Driving the Century of Biology
Rohan Ganesh
Obvious Ventures
Partner
•
-
General
Bold VC Perspectives: How Biotech Gets Funded Today
A curated lineup of leading biotech VCs, each delivering a 5-minute rapid-fire briefing covering: fund focus, investment thesis, selection process, and their most actionable advice for fundraising in the current market
Featuring
Ivan Jaubert
SynBioBeta
Director of Entrepreneurship
Startup-ecosystem builder connecting founders, investors, and corporates.
Omri Amirav-Drory
NFX
General Partner
Scientist-founder VC: built Genome Compiler, now backs techbio.
Blair Willette
KdT Ventures
Investor
Nicole Sonnert
Playground Global
Investment Associate
Elliot Hershberg
Amplify Partners
Partner, Author
Driving the Century of Biology
Rohan Ganesh
Obvious Ventures
Partner
•
-
AIxBIO
Beyond Static Predictions — AI for Protein Dynamics and Multi-Cell Models
The next frontier of biology isn’t in predicting a single static protein structure, but in capturing how proteins move, fold, and interact across time and environments. This session explores how AI can illuminate protein conformations and dynamics, and extend those insights into virtual multi-cellular or tissue models. Experts will discuss the challenge of integrating heterogeneous datasets and instruments, and how breakthroughs in dynamic modeling could reshape drug design, disease understanding, and biomanufacturing. Can we build models that reflect the living, breathing complexity of biology—not just snapshots, but motion?
Featuring
Gabriele Corso
Boltz
CEO
Built DiffDock and the Boltz open-source models reshaping drug discovery.
Peter Clark
Novo Nordisk
VP, CDD
Computational drug-design leader, shipped candidates from CAR-T to peptides.
Theofanis Karaletsos
Achira
Co-founder
Tanja Kortemme
UCSF
Vice Dean of Research
De novo protein-design pioneer; NIH Pioneer Award winner.
Elliot Hershberg
Amplify Partners
Partner, Author
Driving the Century of Biology
•
-
AIxBIO
Beyond Static Predictions — AI for Protein Dynamics and Multi-Cell Models
The next frontier of biology isn’t in predicting a single static protein structure, but in capturing how proteins move, fold, and interact across time and environments. This session explores how AI can illuminate protein conformations and dynamics, and extend those insights into virtual multi-cellular or tissue models. Experts will discuss the challenge of integrating heterogeneous datasets and instruments, and how breakthroughs in dynamic modeling could reshape drug design, disease understanding, and biomanufacturing. Can we build models that reflect the living, breathing complexity of biology—not just snapshots, but motion?
Featuring
Gabriele Corso
Boltz
CEO
Built DiffDock and the Boltz open-source models reshaping drug discovery.
Peter Clark
Novo Nordisk
VP, CDD
Computational drug-design leader, shipped candidates from CAR-T to peptides.
Theofanis Karaletsos
Achira
Co-founder
Tanja Kortemme
UCSF
Vice Dean of Research
De novo protein-design pioneer; NIH Pioneer Award winner.
Elliot Hershberg
Amplify Partners
Partner, Author
Driving the Century of Biology
Session lineup still growing
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Featuring
Speaker Coming Soon
